White label – Pompe disease - ClinicalTrials.eu

Long-Term Safety Study of NTLA-2001 for Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy or Transthyretin Amyloidosis-Related Cardiomyopathy

Recruiting

4 1 1
Investigated Drugs:
- Single Guide Rna Targeting The Human Ttr Gene
- Ziclumeran
Study of Radium-224 in Patients with Advanced Ovarian, Fallopian Tube, or Peritoneal Cancer with Peritoneal Metastasis Undergoing Chemotherapy and Surgery

Recruiting

2 1 1
Investigated Drugs:
- Radium-224 Adsorbed In Calcium Carbonate Microparticles
Study on Colchicine and Opium for Preventing Heart and Kidney Issues in Patients with Moderate Chronic Kidney Disease

Recruiting

3 1 1
Investigated Diseases:
- Nephropathy
Investigated Drugs:
Study on Intermittent vs. Continuous Panitumumab and FOLFIRI for Patients with Unresectable Left-Sided Metastatic Colorectal Cancer

Recruiting

3 1 1 1
Investigated Diseases:
- Colorectal cancer metastatic
Investigated Drugs:
- Panitumumab
Study of Amivantamab, Lazertinib, and Pemetrexed for Patients with Advanced or Metastatic Solid Tumors, Including EGFR-Mutated Non-Small Cell Lung Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
Study on Pancreas Removal and Islet Cell Transplant for Patients with Pancreatic Cancer at High Risk of Post-Surgery Leaks

Recruiting

2 1 1
Investigated Diseases:
- Pancreatic carcinoma
Investigated Drugs:
- Autologous Pancreatic Islets
Study of Activated NK Cells for Treating Sarcomas in Children, Adolescents, and Young Adults

Recruiting

2 1 1
Investigated Diseases:
- Sarcoma
Investigated Drugs:
- Allogeneic Peripheral Blood-Derived Cd56+ Natural Killer Cells, Co-Cultured With K562-Mb15-41Bbi Cell Line
Study on MDMA-Assisted Therapy for Patients with Treatment-Resistant PTSD

Recruiting

2 1 1
Investigated Diseases:
- Post-traumatic stress disorder
Investigated Drugs:
- Midomafetamine Hydrochloride
Study on BI-1808 and Pembrolizumab for Patients with Advanced Solid Tumors

Recruiting

2 1 1 1
Investigated Drugs:
- Bi-1808
- Pembrolizumab
Study on Solifenacin, Mirabegron, and Their Combination for Treating Overactive Bladder and Daytime Urinary Incontinence in Children Aged 5 to 14 Years

Recruiting

3 1 1 1
Investigated Diseases:
- Incontinence
- Urinary incontinence
Investigated Drugs:
- Mirabegron
- Solifenacin Succinate

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies